Evidence map›Paper›PMID 24366221›Full record

ReviewThe American journal of the medical sciences2014

The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope.

Lesley Ann Saketkoo, Jeanette H Magnus, Mittie K Doyle

Abstract readCase ReportsReview
In one paragraph

Review in The American journal of the medical sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Systemic Sclerosis and Perceptions of Quality in Primary Care.The American journal of the medical sciences · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Lesley Ann SaketkooDepartment of Medicine (LAS), Scleroderma and Sarcoidosis Patient Care and Research Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Institute for Health and Society Medical School (JHM), University of Oslo, Norway; Alexion Pharmaceuticals (MKD), Translational Medicine Group, Cambridge, Massachusetts; and Tulane Xavier National Center of Excellence in Women's Health (JHM, MKD), The Mary Amelia Douglas-Whited Community Women's Health Education Center and Tulane University School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana.
Jeanette H Magnus
Mittie K Doyle
Alexion Pharmaceuticals (United States) · USLouisiana State University Health Sciences Center New Orleans · USUniversity of Oslo · NO

Funding

Tulane Building Interdisciplinary Research Careers in Women's Health (BIRCWH)K12HD043451 · NICHD · TULANE UNIVERSITY OF LOUISIANA · PI KROUSEL-WOOD, MARIE · 2002 to 2023
$9.9M
NICHD NIH HHS K12 HD043451
6 · The paper itself

Abstract

Systemic sclerosis (SSc) is a disease of unknown causative factor that manifests as a heterogenous group of multiorgan system manifestations and is characterized by vasculopathy and fibrosis of the skin and internal organs, with mortality related to pulmonary, cardiac, renal or gastrointestinal involvement. The prevalence of SSc may be underestimated in the general population. Cases are often undiagnosed or misdiagnosed, particularly cases with mild or no skin manifestations. Because of late referrals to rheumatologic care, many moderate-to-severe cases progress to irreversible end-organ damage that might have been prevented by early diagnosis. Early diagnosis of SSc with initiation of appropriate treatment is essential, with great impact on morbidity and mortality. This review examines presenting features, ensuing complications and treatment providing a focus on SSc as a treatable disease. Primary care providers play a pivotal role in recognizing initial symptoms associated with SSc and securing early diagnosis through early referral to specialists.

Indexed as

Early DiagnosisHopePhysicians, Primary CareAdultFemaleHumansMaleMass ScreeningMiddle AgedMultiple Organ FailurePrevalenceReferral and ConsultationScleroderma, Systemic

Identifiers

PMID24366221
PMCPMC3872337
OpenAlexW2053599847

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.